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Abstract 
In the September and November 2006 issues of Nature Clinical 
Practice Nephrology, two articles regarding living unrelated 
kidney donor transplantation alluded to the practices in Iran. 
Having served in the planning, supervision and implementation 
of various aspects of health care in Iran, including organ 
transplantation (ANH), and as transplant nephrologists who have 
actively participated in the care of transplanted patients in Iran 
(ANH and NG), we feel obligated to elucidate the realities 
surrounding organ transplantation in Iran. So that unbiased 
researchers are provided with information to judge for 
themselves. 
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Introduction  
Renal replacement therapy, in the form of hemodialysis, was 
initiated in Iran in 1965, and because of limitations on resources, 
patients over the age of 55 were excluded from treatment. The 
first kidney transplantation was carried out at Shiraz University 
in 1967 and while 114 kidney transplantations (living and 
deceased donor) had been performed prior to the 1979 
revolution, no specific legislation regarding organ transplantation 
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Following the 1979 revolution, because of problems inherent in 
the collapse of a political, administrative and economical system, 
and because of sanctions and embargoes imposed on Iran, as 
well as the Iran–Iraq war, acquiring supplies and equipment for 
dialysis became increasingly difficult. At the same time, in 
accordance with the goal of providing health care to all Iranians 
requiring dialysis, the age limit was lifted. Considering the 
increasing prevalence of chronic kidney disease among the 
elderly, particularly among patients with diabetes and 
hypertension, the total number of patients on renal replacement 
therapy continued to increase Maintenance hemodialysis 
treatment was initiated in an increasing number of patients with 
baseline cardiovascular co-morbidity, translating into an 
increased mortality among dialysis patients. In view of this 
reality and because of inaccessibility to deceased donors, 
clinicians, academicians and planners felt the need to initiate 
living related donor transplantations. Within a short period of 
time, the waiting list for organ transplantation expanded.4 In 
order to relieve the shortage, the decision was made to proceed 
with living unrelated donor transplantation in a lawful and 
transparent manner, with full government scrutiny and a strict 
and clear protocol that will be delineated over the next few 
paragraphs. 
From a historical and sociological perspective, it is noteworthy 
that all this was happening at a time when Iran was involved in a 
devastating war and groups of Iranians were volunteering en 
masse to sacrifice their lives for their beliefs and goals. This 
mentality of sacrifice carried over to the willingness to donate an 
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being. Having witnessed the genuine feelings firsthand, we feel it 
is unfortunate that some of our learned colleagues and respected 
researchers use the terminology "sale of kidneys" instead of 
"donation of kidneys". In our view, they have preferred to view 
the glass as half empty, rather than half full. 
Responsible members of the medical care establishment, the 
Iranian Society of Nephrology and Organ Transplantation and 
physicians have been proactive in avoiding the unethical 
practices prevalent in some countries, which have raised concern 
around the world. They have emphasized and diligently 
maintained the highest ethical principles in organ transplantation 
practices by implementing the following protocol: 
 
1. For living donor transplantation: 
 In an effort to eliminate "brokers" and "middlemen", the 
Dialysis and Transplant Patients Association (DATPA; an 
official non-profit organization, equivalent to the National 
Kidney Foundation) scrutinizes the process of organ 
donation. Members of this foundation are patients with 
kidney failure who volunteer their time, receiving no 
financial benefits. They ensure that all regulations are 
followed. 
 Members of the transplantation team have no role in 
identifying potential donors. 
 The central government and non-profit/charitable 
organizations have combined their efforts and resources to 
acknowledge the altruism of the donors. This takes the form 
of a monetary gift as a "token of appreciation", automatic 
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opportunity to attend the annual appreciation event dedicated 
to donors. 
 Transplantation from Iranian donors to non-Iranians is 
banned. 
 Transplantation from immigrant donors to Iranians is 
likewise banned. 
 Prior to transplantation, the donor is examined by a 
nephrologist and fully assessed by the transplantation team, 
to assure safety of donation. In the event that the team feels 
donation might harm the donor, donation will be cancelled. 
 In order to minimize donor morbidity, laparoscopic 
nephrectomy is promoted. 
 For the last two years, a national task force has been studying 
the outcome of living kidney donors with the goal of 
establishing a specific 'Donor Support Network'. The report 
of the task force will be published shortly. 
2. For deceased donor transplantation: 
Although the religious sanction for use of cadaveric organs in an 
effort to save the life of a fellow human being had previously 
been issued by religious leaders, the actual law permitting 
cadaveric organ transplantation was not ratified by the legislature 
until 2002. The new legislation has promoted the performance of 
numerous deceased-donor organ transplantations, involving 
kidney, liver, heart and lungs. 
There is a concerted effort to expand the cadaveric 
transplantation program, as well as hemodialysis and peritoneal 
dialysis units. Fortunately, all these services are provided free of 
charge to patients. Candidates for kidney transplantation are 


























Quarterly Journal of Medical Ethics          Vol 2, No 5, Fall 2008 
  
workup. The living unrelated donor transplantation program 
operates under the close supervision and scrutiny of the Ministry 
of Health and Medical Education, The Iranian Scientific Society 
of Organ Transplantation, the Foundation for Patients with 
Special Diseases, and DATPA. This strict scrutiny, along with 
the universal availability of transplantation, avoids exploitation, 
minimizing any chance of unethical conduct. 
Thus far, over 19,000 kidney transplantations have been 
performed in Iran, and excellent results of living donor 
transplantation have been reported by several Iranian researchers 
in reputable medical journals. Furthermore, we feel it is very 
important that the Iranian medical community has not been 
indifferent to the health of the donors, maintaining a vigilant 
interest in donor outcomes.  
Several studies have addressed the concerns regarding 
exploitation of the poor and the illiterate in the donation process. 
A study of 478 living unrelated donors enrolled from 30 
transplant centers confirms that the donation process is broker-
free, with 96% of the donors having been referred by DATPA. 
This study also found that 91% of the donors expressed 
satisfaction with their donation and 53% suggested kidney 
donation to others. Sixty-three percent of the donors noted that 
the reward they received for donation had a moderate positive 
effect on their economic status, mostly through helping with 
their debts. A large proportion of the donors (90.8%) had at least 
a high school education, and 6.5% had university education. This 
is also confirmed by other studies which have, in addition, 
shown that donors are similar to their recipients in terms of 
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In conclusion, it is our belief that because of the multitude of 
unique and critical issues surrounding organ transplantation, 
there is always a valid concern about misconduct and unethical 
practice. This is true for all countries, including the US, which is 
certainly not immune from unethical acts involving organ 
brokers, as evidenced by reports in the American press. In 
certain developing countries, much of the exploitation and 
unscrupulous acts result from poverty and financial need. In 
those situations, the physicians and patients are not to be blamed. 
Rather, the fault lies with the lack of an infrastructure for 
supervision of living unrelated organ donation. We propose that 
the Iranian model, with support from governmental and non-
profit organizations, is an efficient and ethical model that can be 
employed not only by developing nations, but also by some 
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